Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma.
Ontology highlight
ABSTRACT: PTEN is one of the most frequently altered tumor suppressor genes in malignant tumors. The dominant-negative effect of PTEN alteration suggests that the aberrant function of PTEN mutation might be more disastrous than deletion, the most frequent genomic event in glioblastoma (GBM). This study aimed to understand the functional properties of various PTEN missense mutations and to investigate their clinical relevance. The genomic landscape of PTEN alteration was analyzed using the Samsung Medical Center GBM cohort and validated via The Cancer Genome Atlas dataset. Several hotspot mutations were identified, and their subcellular distributions and phenotypes were evaluated. We established a library of cancer cell lines that overexpress these mutant proteins using the U87MG and patient-derived
SUBMITTER: Choi SW
PROVIDER: S-EPMC8027895 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA